Viewing Study NCT00368251


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-29 @ 7:29 PM
Study NCT ID: NCT00368251
Status: COMPLETED
Last Update Posted: 2023-05-31
First Post: 2006-08-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
Sponsor: UCB Pharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: N01236
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators